There have not been studies specifically dedicated to investigating the protective effects of ω-3 PUFAs on specific biomarkers such as S100β, HMGB1, and NSE in depression across animal models as well as pre-clinical and clinical research specifically related to depression. Here, ENO2 is linked to depressive symptom measurement.